(Q47350576)

14 January 2018

title

Heparanase neutralizes the anticoagulation properties of heparin and low-molecular-weight heparin (English)

1 reference

14 January 2018

1 reference

1 reference

Nasser NJ

1

1 reference

14 January 2018

Sarig G

2

1 reference

14 January 2018

Brenner B

3

1 reference

14 January 2018

Nevo E

4

1 reference

14 January 2018

Goldshmidt O

5

1 reference

14 January 2018

Zcharia E

6

1 reference

14 January 2018

Li JP

7

1 reference

14 January 2018

Vlodavsky I

8

1 reference

14 January 2018

publication date

1 March 2006

1 reference

14 January 2018

Journal of Thrombosis and Haemostasis

published in

1 reference

14 January 2018

volume

4

1 reference

14 January 2018

issue

3

1 reference

14 January 2018

page(s)

560-565

1 reference

14 January 2018

Structure and biological interactions of heparin and heparan sulfate

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Functions of cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Heparanase: a key enzyme involved in cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Heparanases and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Heparanase, a potential regulator of cell-matrix interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Cloning and functional expression of a human heparanase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Human heparanase. Purification, characterization, cloning, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Heterodimer formation is essential for heparanase enzymatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Degradation of heparin proteoglycan in cultured mouse mastocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Processing of macromolecular heparin by heparanase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Substrate specificity of heparanases from human hepatoma and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Glycosaminoglycans and the regulation of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Mechanism of activation of human heparanase investigated by protein engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Further characterization of the antithrombin-binding sequence in heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

An expanding role for antithrombotic therapy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Human platelet heparanase: purification, characterization and catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

A dose-determining trial of heparinase-I (Neutralase) for heparin neutralization in coronary artery surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Cancer and thrombosis: mechanisms and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

Mode of action of unfractionated and low molecular weight heparins on the generation of thrombin in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2006.01792.X

10.1111/J.1538-7836.2006.01792.X

21 January 2018

Identifiers

DOI

1 reference

14 January 2018

1 reference

14 January 2018